Predictive Value of the Anti-Angiogenic Factors in Women with Chronic Kidney Disease - DOH-Net
The Diabetes, Obesity and Hypertension in Pregnancy Research Network (DOH-Net) is a multi-disciplinary research team of obstetrical, midwifery and maternal-fetal medicine specialists.
DOH-Net, research, diabetes, hypertension, obesity, pregnancy, gestational diabetes, diabetes, obesity and hypertension in pregnancy research network, Sunnybrook Health Sciences Centre, St. Michael's Hospital, McMaster University, obstetrics, midwife, maternal-fetal medicine, specialists, researchers, Toronto, Ontario, Canada, Hamilton, Greater Toronto Area, GTA
post-template-default,single,single-post,postid-502,single-format-standard,bridge-core-3.0.5,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-29.2,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.10.0,vc_responsive

Predictive Value of the Anti-Angiogenic Factors in Women with Chronic Kidney Disease

There is a need for better diagnostic tools to distinguish between the signs that mark the appearance of the pregnancy complication preeclampsia and the worsening of existing chronic kidney disease. To address this need, blood samples from 150 women with chronic kidney disease are collected on three separate occasions. The samples are analyzed using the Health Canada approved test for preeclampsia called the Elecsys PIGF and sFlt-1 immunoassay. The aim of this study is to try to help clinicians better predict the development of preeclampsia in women with chronic kidney disease and avoid unnecessary premature deliveries or delays in treatment. ​

Contact for this study:

Isabel Arruda,